We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




New Guidelines Recommend Surgical Ablation to Reduce Atrial Fibrillation

By HospiMedica International staff writers
Posted on 04 Jan 2017
New clinical practice guidelines issued by the Society of Thoracic Surgeons (STS; Chicago, IL, USA) conclude that surgical ablation as a treatment option for atrial fibrillation (AF) has experienced continued development over the last 30 years, with its frequency and success steadily increasing, and as such deserves a more prominent role in adult cardiac surgery.

In developing the new guidelines, the STS writing committee assessed the safety of surgical ablation for three surgical approaches: primary open atrial operations, where the left atrium is already being opened, such as in mitral valve and/or tricuspid valve repair or replacement; primary closed atrial operations, when the left atrium would not otherwise be open, such as coronary artery bypass grafting (CABG) and/or aortic valve replacement (AVR) operations; and standalone operations when the only goal is to perform surgical ablation to treat AF.

The new clinical practice guidelines offer evidence-based recommendations that include surgical ablation for AF at the time of concomitant mitral operations to restore cardiac rhythm; surgical ablation for AF at the time of concomitant isolated AVR, isolated CABG, and AVR+CABG operations to restore cardiac rhythm; and surgical ablation as a primary standalone procedure to restore cardiac rhythm for symptomatic AF that is resistant to medication or catheter ablation. More...
The new guidelines were published in the January 2017 issue of The Annals of Thoracic Surgery.

“These guidelines represent nearly two years of effort by some of the nation's leading experts in the surgical treatment of atrial fibrillation,” said co-author Professor Vinay Badhwar, MD, of the West Virginia University Heart & Vascular Institute (Morgantown, USA). “It is recognized that surgical ablation impacts long-term outcomes with improvements in normal heart rhythm, quality of life, and stroke reduction. Current evidence reveals that surgical ablation can be performed without significant impact to major complications or death.”

In patients with AF, rapid, disorganized electrical signals cause the atria to quiver, disturbing the normal rhythm between the atria and the ventricles. As a result, the ventricles may beat faster and without a regular rhythm, leading to blood clots, strokes, heart failure, and other complications. Surgical ablation, also known as the maze procedure, involves creating specific and defined lesions in the heart. The resulting scar tissue blocks the abnormal electrical signals, while also creating a controlled path for electricity in the heart to follow.

Related Links:
Society of Thoracic Surgeons
West Virginia University Heart & Vascular Institute

Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: 123RF

AI Platform Screens for Amyloid Cardiomyopathy Using ECG Images

Amyloid cardiomyopathy is a heart disease caused by deposits of misfolded proteins in the cardiac muscle. It is often missed until patients develop serious complications such as heart failure.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.